The startup has completed enrollment of an early-stage study testing a first-of-its-kind treatment for facioscapulohumeral muscular dystrophy, a disease targeted by many other drugmakers.

A little-known protein encoded on the X chromosome is attracting growing attention for its potential role in cancer ...

Molecular biologist Susumu Tonegawa, who made fundamental contributions to immunology and neurobiology and became UC San ...

Gene therapy lung cancer biomarker: Genprex and Roche Diagnostics are partnering to validate a TROP2 test that identifies ...

This study presents a valuable RNA velocity solution which integrates cell differentiation and gene regulation, with a balance between neuralODE and raw gene space. The evidence supporting the claims ...

Spliceosomal introns are noncoding DNA sequences located between exons in many eukaryotic protein-coding genes. Most are removed post-transcriptionally by RNA splicing and do not encode proteins, but ...

The Indian government has strengthened oversight of cell and gene therapies by bringing the novel modalities into the Centrally License Approving Authority (CLAA) framework. Central and state ...

Before the advent of modern life saving medicines, the immune system protected human beings from deadly pathogens and foreign objects for thousands of years. Given that the diversity of pathogens and ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--#ASGCT2026--Encoded Therapeutics, Inc. (“Encoded”), a clinical‑stage biotechnology company developing precision genetic medicines for severe neurological ...

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. BOSTON — A medicine increasingly used to ...

Encoded Therapeutics, Inc. (“Encoded”), a clinical‑stage biotechnology company developing precision genetic medicines for severe neurological disorders, today will present an expanded dataset from the ...